ETF · holdings as filed 2025-09-30

What's inside IBB?

iShares Biotechnology ETF
Holdings
253
positions in the fund
Top 10
52%
of fund assets
Expense ratio
0.44%
net, per year
Fund size
$6B
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
V
VRTXVERTEX PHARMACEUTICALS INC
6.77%
2
G
GILDGILEAD SCIENCES INC
6.64%
3
A
AMGNAMGEN INC
6.63%
4
R
REGNREGENERON PHARMACEUTICALS
5.03%
5
A
ALNYALNYLAM PHARMACEUTICALS INC
5.02%
6
A
ARGXARGENX SE - ADR
2.78%
7
I
INSMINSMED INC
2.61%
8
M
MTDMETTLER-TOLEDO INTERNATIONAL
2.20%
9
N
NTRANATERA INC
1.87%
10
O
ONCBEONE MEDICINES LTD-ADR
1.86%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
B
BISXXBCF INSTITUTIONAL-SL AGNCY
11.65%
2
V
VRTXVERTEX PHARMACEUTICALS INC
6.77%
3
G
GILDGILEAD SCIENCES INC
6.64%
4
A
AMGNAMGEN INC
6.63%
5
R
REGNREGENERON PHARMACEUTICALS
5.03%
6
A
ALNYALNYLAM PHARMACEUTICALS INC
5.02%
7
I
IQVIQVIA HOLDINGS INC
2.81%
8
I
INSMINSMED INC
2.61%
9
M
MTDMETTLER-TOLEDO INTERNATIONAL
2.20%
10
N
NTRANATERA INC
1.87%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold IBB alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2025-09-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.